Article 31 -EMA to review ranitidine medicines following detection of NDMA

      Under Article 31 of Directive 2001/80/EC, the review of ranitidine containing medicines was initiated at the request to the European Commission. This review will be carried out by the Committee for Medicinal Products for Human Use (CHMP). The CHMP opinion will then be forwarded...

Read More